Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Anti-obesity potential of Porelis, a standardized extract of purple tea (Camellia sinensis), via modulation of obesityrelated inflammation in RAW264.7 macrophages and antiadipogenesis in 3T3-L1 cells

Kuluvar Gouthamchandra1 , Heggar Venkataramana Sudeep1, Bhoomika Ranganath1, Amritharaj1, Lingaraju Harakanahalli Basavegowda2, TP Prasanna Kumara3, Shyam Prasad Kodimule2,3

1Department of Biomedicinal Research,; 2Department of Phytochemistry,; 3Department of Analytical Development Research Laboratory, R & D Centre for Excellence, Vidya Herbs Pvt. Ltd, #14A, Jigani I Phase, Bangalore-560105, Karnataka, India.

For correspondence:-  Kuluvar Gouthamchandra   Email: goutham06@gmail.com

Received: 26 July 2024        Accepted: 2 January 2025        Published: 28 January 2025

Citation: Gouthamchandra K, Sudeep HV, Ranganath B, Amritharaj , Basavegowda LH, Kumara TP, et al. Anti-obesity potential of Porelis, a standardized extract of purple tea (Camellia sinensis), via modulation of obesityrelated inflammation in RAW264.7 macrophages and antiadipogenesis in 3T3-L1 cells. Trop J Pharm Res 2025; 24(1):31-38 doi: 10.4314/tjpr.v24i1.5

© 2025 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To assess the effect of Porelis, a standardized extract of purple tea (Camellia sinensis) on inflammation in RAW 264.7 cells, anti-adipogenesis and lipid accumulation in 3T3-L1 cells. Methods: Viability of RAW 264.7 and 3T3L1 cells was determined by MTT assay. Lipopolysaccharide (LPS) was used to induce inflammation in RAW264.7 cells. Nitric oxide (NO) generation and levels of anti-inflammatory cytokines (TNF-α and IL-6) were determined using Gries reagent and ELISA, respectively. In addition, Oil-O red staining was carried out to assess the differentiation of 3T3L cells. Furthermore, Western blotting was used to quantify the protein expressions of PPAR- γ, C/EBP and SREBP-1 while RT-PCR was used to determine leptin and FAS mRNA expression. Results: Porelis comprised 3 – 5 % of 1,2-di-O-galloyl-4,6-O-(S)-hexahydroxydiphenoyl-β-D-glucose (GHG). Its use significantly inhibited the generation of NO, IL-6 and TNF-α in LPS-stimulated RAW 264.7 cells (p < 0.0001). Interestingly, there was a significantly inhibited adipocyte differentiation, fat accumulation and protein expression of PPARγ and CEBPα in a dose-dependent manner (p < 0.0001). The mRNA levels of leptin and FAS were significantly (p < 0.0001) upregulated in differentiated adipocytes compared to preadipocytes. Furthermore, treatment with Porelis significantly inhibited mRNA expression levels of leptin and FAS. Conclusion: Porelis may exert anti-inflammatory activity by inhibiting inflammatory responses in RAW264.7 macrophages as well as anti?obesity activity by blocking fat accumulation via inhibition of adipogenesis in 3T3L adipocytes. This study shows that Porelis could be a promising dietary supplement for prevention of inflammation and obesity.

Keywords: Porelis, Purple tea, Cytokines, Adipogenesis, Oil-O red staining, Transcription factor

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2025; 24: 
1
2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates